Yayınlar & Eserler

Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 14

Metabolic Dysfunction-Associated Steatotic Liver Disease in the MENA Region: Setting a Research and Action Priority Agenda

El-Kassas M., Alswat K. A., Yilmaz Y., Labidi A., Sanai F. M., Awad A., et al.
LIVER INTERNATIONAL , cilt.45, sa.6, 2025 (SCI-Expanded) identifier identifier identifier

Pruritus and Fatigue in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study of Turkish Patients From the Global NASH/MASH Registry

YILMAZ Y., Keklikkiran Ç., Racila A., Stepanova M., Younossi Z.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY , cilt.16, sa.6, 2025 (SCI-Expanded) identifier identifier identifier

Prevalence and Associated Factors of Non-Alcoholic Fatty Liver Disease in People Living with HIV-1

Karatas F. N., Keklikkiran Ç., Yilmaz Y., Ay P., Korten V., Sili U.
CURRENT HIV RESEARCH , 2025 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Türkiye: A forensic autopsy study

Ergenc I., Kara E., Yilmaz M. E., DEMİRTAŞ C. Ö., Keklikkiran Ç., Das T., et al.
HELIYON , cilt.10, sa.14, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease

Younossi Z. M., AlQahtani S. A., Funuyet-Salas J., Romero-Gómez M., YILMAZ Y., Keklikkiran Ç., et al.
JHEP REPORTS , cilt.6, sa.7, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Diagnostic accuracy of AGILE 3+score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis

Dalbeni A., Lombardi R., Henrique M., Zoncape M., Pennisi G., Petta S., et al.
HEPATOLOGY , cilt.79, sa.5, ss.1107-1116, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease

Younossi Z. M., Alqahtani S. A., Alswat K., YILMAZ Y., Keklikkiran Ç., Funuyet-Salas J., et al.
JOURNAL OF HEPATOLOGY , cilt.80, sa.3, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Can Frequent Toothbrushing Reduce the Risk of Cirrhosis among Patients with Non-alcoholic Fatty Liver Disease? Hints from a Registry-based Study

Keklikkiran Ç., Stepanova M., Younossi Z., Yilmaz Y.
DIGESTIVE DISEASES , cilt.41, sa.6, ss.932-937, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study

Yilmaz Y., Toraman A. E., Alp C., Doğan Z., Keklikkiran Ç., Stepanova M., et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS , cilt.57, sa.2, ss.215-223, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study

Demirtas C. O., Keklikkiran Ç., Ergenc I., Erturk Sengel B., Eskidemir G., Cinel I., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Evaluation of the Association between <i>Programmed Cell Death</i>-<i>1</i> Gene Polymorphisms and Hepatocellular Carcinoma Susceptibility in Turkish Subjects. A Pilot Study

Demirci A. F., Demirtas C. O., Eren F., Yilmaz D., Keklikkiran Ç., Ozdogan O. C., et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES , cilt.29, sa.4, ss.617-622, 2020 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease.

Kaya E., Bakir A., Kani H., Demirtas C., Keklikkiran Ç., Yilmaz Y.
Gut and liver , cilt.14, ss.486-491, 2020 (SCI-Expanded) identifier identifier identifier

External validation of the Toronto hepatocellular carcinoma risk index in Turkish cirrhotic patients

Demirtas C., Gunduz F., Kani H., Keklikkıran Ç., Alahdab Y., Yılmaz Y., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.32, sa.7, ss.882-888, 2020 (SCI-Expanded) identifier identifier identifier

Arterial stiffness is associated independently with liver stiffness in biopsy-proven nonalcoholic fatty liver disease: a transient elastography study.

Bilgin B., Sunbul M., Kani H. T., Demirtas C., Keklikkiran Ç., Yilmaz Y.
European journal of gastroenterology & hepatology , cilt.32, ss.54-57, 2020 (SCI-Expanded) identifier identifier identifier
Diğer Dergilerde Yayınlanan Makaleler 1

Causes of erectile dysfunction in non-alcoholic fatty liver disease

KANİ H. T., ŞENER T. E., Aykut U. E., DEMİRTAŞ C. Ö., Keklikkiran Ç., Ergenc I., et al.
HEPATOLOGY FORUM , cilt.2, sa.2, ss.60-63, 2021 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

THE IMPACT OF SUPERIMPOSED METABOLICDYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE ( MASLD) ON CLINICAL AND PATIENT- REPORTED OUTCOMES ( PROS) PROFILE OF PATIENTS WITH CHRONIC HEPATITIS B ( CHB) AND C ( CHC)

Younossi Z., Buti M., Papatheodoridis G., YILMAZ Y., Yu M., El-Kassas M., et al.
The Liver Meeting, California, Amerika Birleşik Devletleri, 15 - 19 Kasım 2024, cilt.80, (Özet Bildiri) identifier
Metrikler

Yayın

16

Atıf (WoS)

217

H-İndeks (WoS)

7

Atıf (Scopus)

221

H-İndeks (Scopus)

7

Atıf (Scholar)

5

H-İndeks (Scholar)

1

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları